Treatment of diabetic complications with hydantoins
申请人:Alcon Laboratories, Inc.
公开号:US04464385A1
公开(公告)日:1984-08-07
6-Methythio and 6-methylsulfinyl spiro-chroman-imidazolidine diones useful in the treatment of complications arising from diabetes mellitus.
6-甲基硫和6-甲基磺酰基螺环-色酮咪唑啉二酮,可用于治疗糖尿病引起的并发症。
Hydantoin therapeutic agents
申请人:ALCON LABORATORIES, INC.
公开号:EP0092386A2
公开(公告)日:1983-10-26
6-methythio and 6-methylsulfinyl spiro-chromanimidazol- idine diones useful in the treatment of complications arising from diabetes mellitus.
可用于治疗糖尿病并发症的 6-甲硫基和 6-甲磺基螺-铬并咪唑-啶二酮。
[EN] HYDANTOIN THERAPEUTIC AGENTS
申请人:ALCON LABORATORIES, INC.
公开号:WO1983003542A1
公开(公告)日:1983-10-27
(EN) 6-methylthio and 6-methylsufinyl spiro-chromanimidazolidine diones useful in the treatment of complications arising from diabetes mellitus. The activity of the compounds is surprising in view of the size of the 6-substituents when compared to the prior art compounds. (FR) 6-méthylthio et 6-méthylsulfinyl spiro-chromanimidazolidine diones sont utiles pour traiter les complications dues au diabète sucré. L'activité des composés est surprenante lorsque l'on compare la grandeur des substituants en position 6 par rapport aux composés de l'art antérieur.